China NT Pharma Group Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 7.37 million. Net loss was CNY 143.59 million compared to CNY 66.41 million a year ago.

Basic loss per share from continuing operations was CNY 0.0169 compared to CNY 0.0263 a year ago. Diluted loss per share from continuing operations was CNY 0.0169 compared to CNY 0.0263 a year ago. Basic loss per share was CNY 0.0726 compared to CNY 0.0349 a year ago.

Diluted loss per share was CNY 0.0726 compared to CNY 0.0349 a year ago.